Aspects of excitatory/inhibitory synapses in multiple brain regions are correlated with levels of brain-derived neurotrophic factor/neurotrophin-3

被引:4
|
作者
Shinoda, Yo [1 ,2 ,3 ]
Sadakata, Tetsushi [3 ,4 ]
Yagishita, Kaori [2 ]
Kinameri, Emi [3 ]
Katoh-Semba, Ritsuko [2 ,3 ]
Sano, Yoshitake [2 ]
Furuichi, Teiichi [2 ,3 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Environm Hlth, Hachioji, Tokyo 1920392, Japan
[2] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan
[3] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan
[4] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Maebashi, Gunma 3718511, Japan
关键词
CADPS2; BDNF; NT-3; Excitatory synapse; Inhibitory synapse; FACTOR MESSENGER-RNA; FACTOR BDNF; SYNAPTIC-TRANSMISSION; ACTIVATOR PROTEIN; COPY NUMBER; EXPRESSION; CAPS2; MICE; SECRETION; RELEASE;
D O I
10.1016/j.bbrc.2018.12.100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Appropriate synapse formation during development is necessary for normal brain function, and synapse impairment is often associated with brain dysfunction. Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) are key factors in regulating synaptic development. We previously reported that BDNF/NT-3 secretion was enhanced by calcium-dependent activator protein for secretion 2 (CADPS2). Although BDNF/NT-3 and CADPS2 are co-expressed in various brain regions, the effect of Cadps2-deficiency on brain region-specific BDNF/NT-3 levels and synaptic development remains elusive. Here, we show developmental changes of BDNF/NT-3 levels and we assess disruption of excitatory/inhibitory synapses in multiple brain regions (cerebellum, hypothalamus, striatum, hippocampus, parietal cortex and prefrontal cortex) of Cadps2 knockout (KO) mice compared with wild-type (WT) mice. Compared with WT, BDNF levels in KO mice were reduced in young/adult hippocampus, but increased in young hypothalamus, while NT-3 levels were reduced in adult cerebellum and young hippocampus, but increased in adult parietal cortex. Immunofluorescence of vGluT1, an excitatory synapse marker, and vGAT, an inhibitory synapse marker, in adult KO showed that vGluT1 was higher in the cerebellum and parietal cortex but lower in the hippocampus, whereas vGAT was lower in the hippocampus and parietal cortex compared with WT. Immunolabeling for both vGluT1 and vGAT was increased in the parietal cortex but vGAT was decreased in the cerebellum in adult KO compared with WT. These data suggest that CADPS2-mediated secretion of BDNF/NT-3 may be involved in development and maturation of synapses and in the balance between inhibitory and excitatory synapses. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 50 条
  • [21] Serum Levels of Brain-Derived Neurotrophic Factor, Nerve Growth Factor, Neurotrophin-3, and Glial-Derived Neurotrophic Factor in Children with Specific Learning Disorder
    Uncu, Gokce Sultan
    Karayagmurlu, Ali
    Kaynar, Tuba Bilbay
    Baki, Adile Merve
    Vural, Pervin
    Soylu, Nusret
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2022, 59 (04): : 260 - 267
  • [22] Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats
    Boyce, Vanessa S.
    Park, Jihye
    Gage, Fred H.
    Mendell, Lorne M.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2012, 35 (02) : 221 - 232
  • [23] Serum Brain-Derived Neurotrophic Factor, Glial-Derived Neurotrophic Factor, Nerve Growth Factor and Neurotrophin-3 Levels in Preschool Children with Language Disorder
    Bilgic, Ayhan
    Ferahkaya, Hursit
    Kilinc, Ibrahim
    Energin, Meryem Vesile
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2021, 58 (02): : 128 - 132
  • [24] THE TRKB TYROSINE PROTEIN-KINASE IS A RECEPTOR FOR BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-3
    KLEIN, R
    NANDURI, V
    JING, SQ
    LAMBALLE, F
    TAPLEY, P
    BRYANT, S
    CORDONCARDO, C
    JONES, KR
    REICHARDT, LF
    BARBACID, M
    CELL, 1991, 66 (02) : 395 - 403
  • [25] PURIFICATION AND CHARACTERIZATION OF A BRAIN-DERIVED NEUROTROPHIC FACTOR NEUROTROPHIN-3 (BDNF/NT-3) HETERODIMER
    JUNGBLUTH, S
    BAILEY, K
    BARDE, YA
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 221 (02): : 677 - 685
  • [26] Distribution of the neurotrophins brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 in the postnatal rat brain: An immunocytochemical study
    Friedman, WJ
    Black, IB
    Kaplan, DR
    NEUROSCIENCE, 1998, 84 (01) : 101 - 114
  • [27] Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
    Durany, N
    Michel, T
    Zöchling, R
    Boissl, KW
    Cruz-Sánchez, FF
    Riederer, P
    Thome, J
    SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) : 79 - 86
  • [28] STRUCTURE OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR NEUROTROPHIN 3 HETERODIMER
    ROBINSON, RC
    RADZIEJEWSKI, C
    STUART, DI
    JONES, EY
    BIOCHEMISTRY, 1995, 34 (13) : 4139 - 4146
  • [29] Brain-derived neurotrophic factor (BDNF) determines spontaneous activity levels in the superior colliculus by regulating the strength of inhibitory, but not excitatory synapses
    Rothe, T
    Jüttner, R
    Henneberger, C
    Grantyn, R
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 272 - 272
  • [30] SERUM LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) AND NEUROTROPHIN-3 (NT-3) AND COGNITIVE PERFORMANCE IN SUBJECTS WITH SCHIZOPHRENIA
    Wysokinski, A.
    Kloszewska, I.
    EUROPEAN PSYCHIATRY, 2011, 26